| Literature DB >> 27167432 |
Gisele Chagas de Medeiros1, Fernanda Chiarion Sassi1, Lucas Santos Zambom1, Claudia Regina Furquim de Andrade1.
Abstract
OBJECTIVE: To determine whether the severity of non-neurological critically ill patients correlates with clinical predictors of bronchial aspiration.Entities:
Mesh:
Year: 2016 PMID: 27167432 PMCID: PMC4853064 DOI: 10.1590/S1806-37562015000000192
Source DB: PubMed Journal: J Bras Pneumol ISSN: 1806-3713 Impact factor: 2.624
Sequential Organ Failure Assessment scoring system.
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
| |||||
| PaO2/FiO2, mmHg | > 400 | ≤ 400 | ≤ 300 | ≤ 200a | ≤ 100a |
|
| |||||
| Platelets, ×103/mm3 | > 150 | ≤ 150 | ≤ 100 | ≤ 50 | ≤ 20 |
|
| |||||
| Bilirubin, mg/dL (µmol/L) | < 1.2 (< 20) | 1.2-1.9 (20-32) | 2.0-5.9 (33-101) | 6.0-11.9 (102-204) | > 12.0 (> 204) |
|
| |||||
| Hypotension | No hypotension | MAP < 70 mmHg | Dopamine ≤ 5 or dobutamine at any doseb | Dopamine > 5, epinephrine ≤ 1, or norepinephrine ≤ 0.1b | Dopamine > 15, epinephrine > 0.1, or norepinephrine > 0.1b |
|
| |||||
| Glasgow Coma Scale | 15 | 13-14 | 10-12 | 6-9 | < 6 |
|
| |||||
| Creatinine, mg/dL (µmol/L) | < 1.2 (< 110) | 1.2-1.9 (110-170) | 2.0-3.4 (171-299) | 3.5-4.9 (300-440) | > 5.0 (> 440) |
| Urine output, mL/day | N/A | N/A | N/A | < 500 | < 200 |
MAP: mean arterial pressure; and SNC central nervous system. aWith ventilatory support. bAdrenergic agents (µg/kg body weight/min) were administered for at least 1 h.
Age and duration of intubation in the patients studied.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
| ||
| Age, years | 62.00 ± 17.40 | 55.30 ± 17.48 | 46.40 ± 18.30 | < 0.001 |
| Duration of intubation, days | 7.60 ± 3.97 | 6.20 ± 3.38 | 4.90 ± 2.70 | < 0.001 |
ASHA1: patients at levels 1 and 2, as scored by the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS); ASHA2: patients at levels 3, 4, and 5, as scored by ASHA NOMS; and ASHA3: patients at levels 6 and 7, as scored by ASHA NOMS. *ANOVA.
Comparison of predictors of bronchial aspiration among levels of swallowing function.
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
| |||
|
|
|
| |||
| Extraoral lossa | Pass | 35 | 57 | 50 | 0.402 |
| Fail | 3 | 4 | 1 | ||
| Multiple swallows | Pass | 24 | 42 | 44 | 0.030 |
| Fail | 14 | 19 | 7 | ||
| Abnormal cervical auscultation findings | Pass | 21 | 52 | 51 | < 0.001 |
| Fail | 17 | 9 | 0 | ||
| Wet voice | Pass | 31 | 55 | 51 | 0.009 |
| Fail | 7 | 6 | 0 | ||
| Cough | Pass | 16 | 37 | 50 | < 0.001 |
| Fail | 22 | 24 | 1 | ||
| Choking | Pass | 31 | 52 | 51 | 0.008 |
| Fail | 7 | 9 | 0 | ||
ASHA1: patients at levels 1 and 2, as scored by the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS); ASHA2: patients at levels 3, 4, and 5, as scored by ASHA NOMS; and ASHA3: patients at levels 6 and 7, as scored by ASHA NOMS. aFood or liquid escaping from the mouth or nose. *Chi-square test.
Comparison of patient severity of illness among levels of swallowing function.
|
|
|
|
|
|---|---|---|---|
| ASHA1 | 5.0 | 3.75-8.00 | 0.001 |
| ASHA2 | 5.0 | 3.00-7.00 | |
| ASHA3 | 3.0 | 2.00-5.00 | |
IQR: interquartile range; ASHA1: patients at levels 1 and 2, as scored by the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS); ASHA2: patients at levels 3, 4, and 5, as scored by ASHA NOMS; and ASHA3: patients at levels 6 and 7, as scored by ASHA NOMS. *Kruskal-Wallis test.
Multiple comparisons of patient severity of illness among levels of swallowing function.
|
|
|
|---|---|
| ASHA1 vs. ASHA2 | > 0.999 |
| ASHA1 vs. ASHA3 | 0.003 |
| ASHA2 vs. ASHA3 | 0.005 |
ASHA1: patients at levels 1 and 2, as scored by the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS); ASHA2: patients at levels 3, 4, and 5, as scored by ASHA NOMS; and ASHA3: patients at levels 6 and 7, as scored by ASHA NOMS.*Dunn's test.
Comparison of the severity of involvement of the respiratory, cardiovascular, and central nervous systems among levels of swallowing function.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
| ||
|
|
|
| ||
|
| ||||
| 0 | 8 | 13 | 14 | 0.436 |
| 1 | 14 | 13 | 15 | |
| 2 | 9 | 18 | 7 | |
| 3 | 7 | 14 | 13 | |
| 4 | 0 | 3 | 2 | |
|
| ||||
| 0 | 28 | 49 | 47 | 0.507 |
| 1 | 2 | 3 | 1 | |
| 2 | 1 | 1 | 1 | |
| 3 | 5 | 7 | 1 | |
| 4 | 2 | 1 | 1 | |
|
| ||||
| 0 | 15 | 40 | 43 | 0.001 |
| 1 | 18 | 18 | 8 | |
| 3 | 4 | 2 | 0 | |
| 4 | 3 | 1 | 0 | |
SOFA: Sequential Organ Failure Assessment; ASHA1: patients at levels 1 and 2, as scored by the American Speech-Language-Hearing Association National Outcome Measurement System (ASHA NOMS); ASHA2: patients at levels 3, 4, and 5, as scored by ASHA NOMS; ASHA3: patients at levels 6 and 7, as scored by ASHA NOMS; and CNS: central nervous system. *Chi-square test.